Market Cap | ₹5,368Cr |
ROE | 3.16% |
P/E Ratio(TTM) | 131.60 |
EPS(TTM) | 1.62 |
P/B Ratio | 7.62 |
Dividend Yield | 0.00% |
Industry P/E | 34.68 |
Book Value | 27.99 |
Debt to Equity | 0.68 |
Face Value | 2 |
Parent Organisation | Sequent Scientific |
Managing Director | Mr. Rajaram Narayanan |
NSE Symbol | SEQUENT |
FUND NAME | AUM(%) |
---|---|
UTI Healthcare Fund Direct Growth | 1.48% |
Quant Small Cap Fund Direct Plan Growth | 1.43% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 101.06 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.08 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.52 | ||
Wockhardt | NA (0.00%) | -147.89 |